Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

[Comparison of two types of cell cultures for preparation of sTNFRII-gAD fusion protein].

Huang S, Yin Y, Xiong C, Wang C, Lü J, Gao J.

Sheng Wu Gong Cheng Xue Bao. 2013 Jan;29(1):115-8. Chinese.

PMID:
23631125
2.
3.

Efficient production of sTNFRII-gAD fusion protein in large quantity by use of the modified CHO-S cell expression system.

Cai Q, Zhao A, Yuting Yin, Ma L, Jiao Z, Zhi H, Lai S, Cheng S, Yang H, Lu Y, Siminovitch KA, Gao J.

PLoS One. 2014 Oct 23;9(10):e111229. doi: 10.1371/journal.pone.0111229. eCollection 2014.

4.

[Rapid expression and preparation of the recombinant fusion protein sTNFRII-gAD by adenovirus vector system].

Lu Y, Liu D, Zhang X, Liu X, Shen W, Zheng G, Liu Y, Dong X, Wu X, Gao J.

Sheng Wu Gong Cheng Xue Bao. 2011 Aug;27(8):1239-46. Chinese.

PMID:
22097814
5.

Protective effects of a novel trimerized sTNFRII on acute liver injury.

Luo M, Liu D, Zhang L, Huang S, Yang W, Zhang L, Cui T, Ma H, Wang Z, Sun Q, Xiong C, Zhu J, Li J, Wu X, Jin L, Hu Z, Gao J.

Int Immunopharmacol. 2012 May;13(1):88-92. doi: 10.1016/j.intimp.2012.03.013. Epub 2012 Mar 30.

PMID:
22465962
6.

Bioprocess development for the production of a recombinant MUC1 fusion protein expressed by CHO-K1 cells in protein-free medium.

Link T, Bäckström M, Graham R, Essers R, Zörner K, Gätgens J, Burchell J, Taylor-Papadimitriou J, Hansson GC, Noll T.

J Biotechnol. 2004 May 13;110(1):51-62.

PMID:
15099905
7.

Preventive Effect of a Novel Recombinant sTNFRII on Collagen-Induced Arthritis.

Luo M, Zhao A, Gao H, He L, Guo Y, Tian D, Liu Y, Chen L, Liu P, Hu Z, Gao J.

Immunol Invest. 2015;44(5):470-81. doi: 10.3109/08820139.2015.1030758.

PMID:
26107746
8.

Process parameter shifting: Part I. Effect of DOT, pH, and temperature on the performance of Epo-Fc expressing CHO cells cultivated in controlled batch bioreactors.

Trummer E, Fauland K, Seidinger S, Schriebl K, Lattenmayer C, Kunert R, Vorauer-Uhl K, Weik R, Borth N, Katinger H, Müller D.

Biotechnol Bioeng. 2006 Aug 20;94(6):1033-44.

PMID:
16736530
9.

Batch, fed-batch, and microcarrier cultures with CHO cell lines in a pressure-cycle driven miniaturized bioreactor.

Kim BJ, Zhao T, Young L, Zhou P, Shuler ML.

Biotechnol Bioeng. 2012 Jan;109(1):137-45. doi: 10.1002/bit.23289. Epub 2011 Oct 3.

PMID:
21965160
10.

[Development of a fed-batch process for TNFR-fc producing GS-CHO cells].

Fan L, Zhao L, Sun Y, Kou T, Tan W.

Sheng Wu Gong Cheng Xue Bao. 2010 Feb;26(2):216-22. Chinese.

PMID:
20432941
11.

Improved bioprocess with CHO-hTSH cells on higher microcarrier concentration provides higher overall biomass and productivity for rhTSH.

Ventini DC, Damiani R, Sousa AP, de Oliveira JE, Peroni CN, Ribela MT, Bartolini P, Tonso A, Soares CR, Pereira CA.

Appl Biochem Biotechnol. 2011 Jun;164(4):401-9. doi: 10.1007/s12010-010-9143-5. Epub 2010 Dec 23.

PMID:
21181451
12.

A novel control scheme for inducing angiostatin-human IgG fusion protein production using recombinant CHO cells in a oscillating bioreactor.

Wang IK, Hsieh SY, Chang KM, Wang YC, Chu A, Shaw SY, Ou JJ, Ho L.

J Biotechnol. 2006 Feb 10;121(3):418-28. Epub 2005 Sep 12.

PMID:
16162365
13.
14.

A comparison of the properties of a Bcl-xL variant to the wild-type anti-apoptosis inhibitor in mammalian cell cultures.

Figueroa B Jr, Sauerwald TM, Oyler GA, Hardwick JM, Betenbaugh MJ.

Metab Eng. 2003 Oct;5(4):230-45.

PMID:
14642351
15.

Process parameter shifting: Part II. Biphasic cultivation-A tool for enhancing the volumetric productivity of batch processes using Epo-Fc expressing CHO cells.

Trummer E, Fauland K, Seidinger S, Schriebl K, Lattenmayer C, Kunert R, Vorauer-Uhl K, Weik R, Borth N, Katinger H, Müller D.

Biotechnol Bioeng. 2006 Aug 20;94(6):1045-52.

PMID:
16736532
16.

Production of rhEPO with a serum-free medium in the packed bed bioreactor.

Deng J, Yang Q, Cheng X, Li L, Zhou J.

Chin J Biotechnol. 1997;13(4):247-52.

PMID:
9631260
17.

Novel micro-bioreactor high throughput technology for cell culture process development: Reproducibility and scalability assessment of fed-batch CHO cultures.

Amanullah A, Otero JM, Mikola M, Hsu A, Zhang J, Aunins J, Schreyer HB, Hope JA, Russo AP.

Biotechnol Bioeng. 2010 May 1;106(1):57-67. doi: 10.1002/bit.22664.

PMID:
20073088
18.

Enhanced cell culture performance using inducible anti-apoptotic genes E1B-19K and Aven in the production of a monoclonal antibody with Chinese hamster ovary cells.

Figueroa B Jr, Ailor E, Osborne D, Hardwick JM, Reff M, Betenbaugh MJ.

Biotechnol Bioeng. 2007 Jul 1;97(4):877-92.

PMID:
17099908
19.

Enhancement of transient gene expression and culture viability using Chinese hamster ovary cells overexpressing Bcl-x(L).

Majors BS, Betenbaugh MJ, Pederson NE, Chiang GG.

Biotechnol Bioeng. 2008 Oct 15;101(3):567-78. doi: 10.1002/bit.21917.

PMID:
18727128
20.

Growth, metabolic activity, and productivity of immobilized and freely suspended CHO cells in perfusion culture.

Hilal-Alnaqbi A, Hu AY, Zhang Z, Al-Rubeai M.

Biotechnol Appl Biochem. 2013 Jul-Aug;60(4):436-45. doi: 10.1002/bab.1103. Epub 2013 May 23.

PMID:
23701045
Items per page

Supplemental Content

Write to the Help Desk